Every year, there are an estimated 20 million hepatitis E virus (HEV) infections worldwide,
leading to an estimated 3.3 million symptomatic cases of hepatitis E. HEV is largely …

Objective Better knowledge of hepatitis B virus (HBV) infection prevalence at the national
level can help to implement pertinent strategies to address HBV related burden. The aim …

Hepatitis E virus (HEV), identified over 30 years ago, remains a serious threat to life, health,
and productivity in developing countries where access to clean water is limited. Recognition …

Abstract Background Hepatitis E Virus (HEV) infection is a newly recognized serious threat
to global public health and Africa is suspected to be among the most severely affected …

Background At least 17% of the population in Germany has been infected with the hepatitis
E virus (HEV); thus, HEV infections are more frequent than was previously assumed …

Hepatitis E is an emerging endemic disease found across the African continent, but there
are clear differences in epidemiology between North Africa and countries south of the …

The hepatitis E virus (HEV) is a major cause of acute hepatitis globally. Genotypes 1 and 2
(G1 and G2) are obligate human pathogens transmitted faeco‐orally, leading to epidemics …

Hepatitis E virus (HEV) infection may cause acute hepatitis and lead to hepatic failure in
developing and developed countries. We studied HEV seroprevalences in patients with …

Background The hepatitis E virus (HEV) represents a major cause of acute hepatitis
worldwide. The majority of HEV cases occur in low-income countries, mainly Asia and Africa …

Abstract Background and Aims Hepatitis E is an infectious disease of the liver caused by the
hepatitis E virus (HEV). Immunocompromised patients present a particular risk group, as …